Development
Medtronic plc
MDT
$89.34
-$0.90-1.00%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.03% | 3.73% | 1.57% | -1.45% | -3.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.03% | 3.73% | 1.57% | -1.45% | -3.19% |
| Cost of Revenue | 8.19% | 9.62% | 7.82% | 6.54% | 2.12% |
| Gross Profit | 3.45% | 0.90% | -1.37% | -5.11% | -5.63% |
| SG&A Expenses | 2.32% | 2.37% | 1.83% | 1.13% | 17.60% |
| Depreciation & Amortization | 91.30% | 145.45% | 150.00% | -100.00% | -101.32% |
| Other Operating Expenses | -32.95% | -45.54% | -35.13% | -26.36% | -27.47% |
| Total Operating Expenses | 4.17% | 4.56% | 3.47% | 2.55% | 0.36% |
| Operating Income | 8.75% | 0.39% | -5.83% | -15.90% | -15.97% |
| Income Before Tax | 2.22% | -3.45% | -3.70% | -2.83% | -1.28% |
| Income Tax Expenses | -2.11% | 1.79% | 270.44% | 246.27% | 143.04% |
| Earnings from Continuing Operations | 3.62% | -5.00% | -30.16% | -25.27% | -17.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -45.45% | -15.00% | -61.11% | -13.64% | 0.00% |
| Net Income | 3.40% | -5.09% | -30.47% | -25.44% | -17.32% |
| EBIT | 8.75% | 0.39% | -5.83% | -15.90% | -15.97% |
| EBITDA | 2.60% | -2.57% | -6.92% | -14.15% | -11.45% |
| EPS Basic | 3.59% | -4.60% | -29.97% | -24.74% | -16.53% |
| Normalized Basic EPS | 9.77% | 4.47% | 2.11% | -7.08% | -5.56% |
| EPS Diluted | 3.36% | -4.68% | -29.99% | -24.47% | -16.27% |
| Normalized Diluted EPS | 9.94% | 4.73% | 2.48% | -6.66% | -5.18% |
| Average Basic Shares Outstanding | -0.11% | -0.35% | -0.66% | -0.96% | -1.00% |
| Average Diluted Shares Outstanding | -0.25% | -0.58% | -1.01% | -1.40% | -1.42% |
| Dividend Per Share | 3.00% | 4.58% | 6.23% | 7.94% | 8.10% |
| Payout Ratio | 0.00% | 0.10% | 0.52% | 0.43% | 0.29% |